Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Silence Therapeutics
AddedFeb 20, 2024
UpdatedJun 28, 2026
Silence Therapeutics

Silence Therapeutics

Public

UK biotech co. discovering molecules with RNA tech to target genes in diseases with unmet needs.

HQ
London, Greater London, GB
Founded
1994
Overview
Compare
Fundraising
Employees
Website

Silence Therapeutics, founded in the UK, is a biotechnology company dedicated to transforming lives by developing precision-engineered medicines using RNA technology. Their core mission is to silence diseases through the design and development of short interfering RNAs (siRNAs), targeting specific genes involved in the pathology of diseases with significant unmet medical needs. The company focuses on creating novel therapeutic molecules to address conditions for which current treatment options are limited or inadequate.

Notable figures associated with Silence Therapeutics include a team of pioneering scientists and experienced biotech professionals. The company has garnered attention from prominent investors in the biotech sector, contributing to its growth and innovation. Key achievements include advancing a new generation of siRNA-based medicines and making significant strides in clinical trials. Overall, Silence Therapeutics has had a substantial impact on the field of RNA interference (RNAi) therapeutics, offering hope to patients with previously untreatable conditions.

Silence Therapeutics - Similar Companies

Silvec Biologics logo

Silvec Biologics

silvec.com

Alnylam Pharmaceuticals aln logo

Alnylam Pharmaceuticals aln

alnylam.com

Sirnaomics logo

Sirnaomics

sirnaomics.com

Ionis Pharmaceuticals logo

Ionis Pharmaceuticals

ionispharma.com

Orbital Therapeutics logo

Orbital Therapeutics

Sirius Therapeutics logo

Sirius Therapeutics

siriusrna.com

Kylin Therapeutics logo

Kylin Therapeutics

Quark Pharmaceuticals logo

Quark Pharmaceuticals

ReviR Therapeutics logo

ReviR Therapeutics

revirtx.com

Sixfold Bioscience logo

Sixfold Bioscience

sixfold.bio

Atalanta Therapeutics logo

Atalanta Therapeutics

atalantatx.com

Traversa Therapeutics logo

Traversa Therapeutics

traversathera.com

Nextrna Therapeutics logo

Nextrna Therapeutics

Remix Therapeutics logo

Remix Therapeutics

Solstice Biologics logo

Solstice Biologics

Silence Therapeutics - Quick Facts

Who are Silence Therapeutics' competitors?

Companies similar to Silence Therapeutics include Silvec Biologics, Alnylam Pharmaceuticals aln, Sirnaomics and Ionis Pharmaceuticals.

When was Silence Therapeutics founded?

Silence Therapeutics was founded in 1994.

Where is Silence Therapeutics' headquarters located?

Silence Therapeutics' headquarters is located in London, Greater London, GB.

When was Silence Therapeutics' last funding round?

Silence Therapeutics' most recent funding round was for $120M (USD) in February 2024.

How much has Silence Therapeutics raised to-date?

As of Feb 5, 2024, Silence Therapeutics has raised a total of $248.7M (USD).

How many employees does Silence Therapeutics have?

Silence Therapeutics has 120 employees as of Feb 12, 2024.

Silence Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
  • RNA
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • RNA Therapeutics
Unique IDs
  • ein: 000000000
  • secCik: 0001479615
  • ticker: SLN
  • ticker: SLNCF
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research